Tag: Vaccines
Influenza A(H3N2) Viruses Predominate 2017-2018 Season
Vaccine effectiveness estimated at 25 percent against A(H3N2)
Anti-Heroin Vaccine Shows Promise Against Lethal Doses
TLR9 agonist in presence of alum is stable over 30 days, elicits strong anti-heroin antibody titers
Reminder, Recall Systems Improve Immunization Uptake
Based on high certainty evidence, postcards, text messages, auto-dialer improve receipt of vaccines
Adjuvanted Shingles Subunit Vaccine Likely More Cost-Effective
Less overall cost and more effective than live attenuated vaccine at all ages; generally a good value
Repeated Flu Vaccinations Help Prevent Severe Infection
Annual vaccination found to lessen flu severity, hospitalizations, and death among the elderly
Counseling Linked to Reduction in Vaccine Exemption Rates
Significant drop in rates in Washington after implementation of bill mandating parental counseling
Flu Vaccine Expected to Protect Against Most U.S. H3N2 Viruses
Current vaccine projected to be more effective in 2018 U.S. flu season vs 2017 Australian flu season
Bivalent Meningococcal B Vaccine Safe, Immunogenic
Elicits bactericidal responses against diverse meningococcal B strains in teens, young adults
Best Practice Advice Issued for Hep B Vaccination, Screening
All unvaccinated adults at risk for infection should be vaccinated; screening recommended for at-risk
SMS Reminders Moderately Effective for Flu Vaccination
One additional high-risk patient immunized for every 29 SMSs sent, costing $3.48
